Loading...
XJPX
7733
Market cap13bUSD
Oct 08, Last price  
1,990.00JPY
1D
-0.50%
1Q
13.49%
Jan 2017
97.03%
Name

Olympus Corp

Chart & performance

D1W1MN
XJPX:7733 chart
P/E
32.14
P/S
2.17
EPS
61.91
Div yield, %
1.00%
Shrs. gr., 5y
-2.84%
Rev. gr., 5y
6.71%
Revenues
1.01t
+1.34%
1,061,786,000,0001,128,875,000,000980,803,000,000883,086,000,000847,105,000,000848,548,000,000743,851,000,000713,286,000,000764,671,000,000804,578,000,000740,557,000,000786,497,000,000793,862,000,000755,231,000,000730,544,000,000750,123,000,000881,923,000,000925,752,000,000997,332,000,0001,010,676,000,000
Net income
68.17b
-42.16%
47,799,000,00057,969,000,000-114,810,000,00047,763,000,0003,866,000,000-48,985,000,0008,020,000,00013,627,000,000-8,737,000,00062,594,000,00042,783,000,00057,064,000,0008,147,000,00080,288,000,00057,712,000,000115,742,000,000143,432,000,000242,566,000,000117,855,000,00068,172,000,000
CFO
100.59b
-47.19%
108,400,000,00089,006,000,00041,628,000,00076,245,000,00030,469,000,00030,889,000,00025,233,000,00072,388,000,00066,811,000,00048,621,000,000102,052,000,00095,146,000,00066,943,000,000133,544,000,000124,122,000,000169,729,000,00098,490,000,00042,365,000,000190,463,000,000100,585,000,000
Dividend
Mar 30, 202730 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in Tokyo, Japan, in 1919, Olympus Corporation is a global leader in the manufacturing and distribution of advanced precision machinery and scientific instruments. The company structures its diverse operations into four main segments. Its Endoscopic Solutions division provides sophisticated endoscopic tools for gastrointestinal and surgical procedures, along with complete endoscopy systems and crucial repair services. The Therapeutic Solutions segment delivers specialized medical devices for urology, gynecology, and otolaryngology (ear, nose, and throat), alongside endo-therapy and energy-based devices, and single-use surgical instruments. Under its Scientific Solutions umbrella, Olympus supplies an array of biological and industrial microscopes, industrial inspection equipment including endoscopes and videoscopes, non-destructive testing apparatus, and X-ray fluorescence (XRF) analyzers. The "Others" category encompasses biomedical materials and orthopedic equipment. Furthermore, Olympus's extensive offerings include additional medical technologies such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, supported by system integration and comprehensive maintenance and service programs. The company, which was originally known as Olympus Optical Co., Ltd., officially rebranded as Olympus Corporation in October 2003.

Related entities

Subsidiaries
OLYMPUS GLOBAL TREASURY SERVICES LIMITED

Key people

Bob White
President, Chief Executive Officer, Representative Executive Officer · since 2025
Shigeto Ohtsuki
Executive Officer, Chief Human Resources Officer · since 2023
Syed Naveed
Executive Officer, Chief Technology Officer · since 2025
Simone Berger
Executive Officer, Chief Human Resources Officer · since 2026
Keith Boettiger
Executive Officer · since 2026
John Chepel
Executive Officer, Chief Medical Officer · since 2024
Frank Drewalowski
Executive Officer · since 2025
Masahito Goto
Executive Officer · since 2022
Kota Ishibiki
Executive Officer, President of Subsidiary · since 2025
Tatsuya Izumi
Executive Officer, Chief Financial Officer · since 2024
Hironobu Kawano
Executive Officer · since 2021
Gabriela Kaynor
Executive Officer, Chief Strategy Officer · since 2024
Hidenobu Kimura
Deputy Chief Technology Officer, Executive Officer · since 2025
Stephen Kneebone
Executive Officer · since 2022
Seiji Kuramoto
Executive Officer · since 2022
Pedro Lazaro
Deputy Chief Financial Officer, Executive Officer · since 2025
Gabriel Mchugh
Executive Officer · since 2025
Tetsuaki Mori
Executive Officer · since 2025
Takeshi Ogura
Executive Officer, Deputy Chief Quality Officer · since 2025
Tomohisa Sakurai
Executive Officer · since 2024
IPO date
May 16, 1949
Employees
32,844
Domiciled in
JP
Incorporated in
JP
Headquarters & legal address
石川町2951番地
八王子市, 13 192-8507
JP
Other language
Olympus Corp.

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT